Gut Microbiome and Muscle Mass: The Gut-Muscle Axis Explained

The gut microbiome and muscle mass are connected by a communication network scientists call the gut-muscle axis. Your gut bacteria influence inflammation, nutrient absorption, energy metabolism and hormone signalling, all of which matter for how muscle is built and maintained. Yet much of what circulates online oversimplifies this relationship or overstates what current evidence can prove. This guide explains the biology in plain language, reviews what human and animal studies actually show, separates established findings from early-stage hypotheses, and outlines how diet, exercise and personalised microbiome insight may support muscle health over a lifetime.

The Gut-Muscle Axis: An Overview

The gut-muscle axis describes the bidirectional communication system linking the microbial community in your digestive tract with skeletal muscle, the tissue responsible for movement, posture and much of your metabolic health. It is not a single organ or a single pathway. It is a collection of overlapping routes, including immune signalling, microbial metabolites, hormonal messages and the nervous system, that allow changes in the gut to influence muscle biology and vice versa.

The concept matters because skeletal muscle is far more than a mechanical structure. It is a metabolically active tissue that helps regulate blood glucose, supports immune function and stores amino acids that the body draws on during illness or stress. Muscle mass and muscle strength decline naturally with age, and this decline has been linked with frailty, falls, reduced independence and higher mortality risk. Anything that shifts the balance between muscle building and muscle breakdown is therefore worth understanding.

What the gut microbiome actually is

The gut microbiome is the collective population of bacteria, archaea, fungi and viruses living in your intestines, together with their genes and the molecules they produce. The large intestine alone hosts hundreds of species, and their functions vary widely. Some ferment dietary fibre into short-chain fatty acids. Some interact with the immune system. Others influence how bile acids and amino acids are modified.

An important point for interpreting headlines: microbial composition differs substantially between individuals. Two healthy people can have very different bacterial profiles and similar health markers. Dietary habits, geography, medications, age, stress and genetics all shape the community, and the community shifts over time. This variability is one reason why blanket claims about a single "good" or "bad" bacteria are usually misleading.

Why muscle depends on more than protein

It is reasonable to assume that muscle growth is simply a matter of eating enough protein and lifting weights. Both matter enormously, but muscle maintenance also depends on systemic factors. Chronic low-grade inflammation, insulin sensitivity, hormone levels, gut barrier function and nutrient availability all influence whether muscle protein synthesis outpaces muscle protein breakdown.

The gut microbiome can influence several of these factors simultaneously. That is why researchers describe an "axis" rather than a direct line: the microbiome is not issuing instructions to muscle tissue, but it is adjusting the environment in which muscle operates.

How the communication works

Communication along the gut-muscle axis appears to run through at least four broad channels:

• Metabolic: bacteria produce short-chain fatty acids, bile acid derivatives and other metabolites that enter circulation and influence energy metabolism.
• Immune: microbial signals shape the intensity and tone of systemic inflammation, which is a major driver of muscle breakdown.
• Endocrine and metabolic signalling: the microbiome influences gut hormone release and can affect pathways related to insulin-like growth factor 1 (IGF-1) and AMPK, both involved in muscle protein turnover and energy sensing.
• Barrier function: the gut lining regulates what passes into the bloodstream. When barrier integrity is compromised, a phenomenon often described as "leaky gut", increased bacterial product exposure can drive immune activation.

The relationship also runs in both directions. Exercise and diet alter the gut environment, changes in body composition may affect microbial communities, and muscle-derived signalling molecules may influence gut function. The axis is best understood as a loop, not a one-way street.

Key Mechanisms: How the Microbiome Influences Muscle Mass

Mechanisms are where research on gut bacteria and muscle health becomes both fascinating and complicated. Many proposed pathways are biologically plausible and supported by animal models, but human evidence is often indirect. The following sections explain what each mechanism is, why it might matter for muscle, and where the certainty currently sits.

Ontdek de microbioom test

ISO-gecertificeerd EU-laboratorium • Monster blijft stabiel tijdens verzending • GDPR-veilige gegevens

Microbioom test kit

Short-chain fatty acids: fuel and signals

When you eat dietary fibre, certain gut bacteria ferment it and produce short-chain fatty acids, mainly acetate, propionate and butyrate. These molecules are among the most studied microbial metabolites in human health.

Short-chain fatty acids act as an energy source for cells lining the colon, but they also enter the bloodstream and influence metabolism elsewhere. In muscle research, they have been linked with improved insulin sensitivity, reduced systemic inflammation and effects on mitochondrial function and energy sensing via AMPK. Better insulin sensitivity supports nutrient uptake into muscle, while lower inflammation reduces signals that promote muscle atrophy.

Butyrate in particular has received attention for its role in maintaining the gut barrier and for its anti-inflammatory properties. Because low-grade inflammation is a recognised contributor to muscle loss, particularly in older adults, any factor that modulates inflammatory tone is plausibly relevant.

What remains uncertain: most of these effects have not been demonstrated directly in human muscle tissue at physiologically realistic concentrations. The pathway is well supported in preclinical work, but the size of its contribution to human muscle mass is not established.

Inflammation and immune signalling

Chronic low-grade inflammation is one of the most consistent factors associated with muscle loss, reduced muscle strength and frailty, especially with ageing. Inflammatory cytokines such as TNF-alpha and IL-6 can promote muscle protein breakdown and interfere with muscle protein synthesis.

The gut microbiome influences the immune system continuously. Microbial products interact with pattern-recognition receptors on immune cells, helping to set the baseline level of immune activation. A diverse, stable microbiome is generally associated with a more balanced inflammatory profile, while dysbiosis, an unfavourable shift in composition, has been linked with increased immune activation.

This makes inflammation a central candidate mechanism for the gut-muscle axis. It also explains why researchers focus on fibre intake, gut barrier integrity and bacterial diversity rather than on single organisms.

Bile acids

Your liver produces bile acids to help digest fats. Gut bacteria modify them into secondary bile acids, which act as signalling molecules rather than mere detergents. These modified bile acids interact with receptors involved in energy metabolism and inflammation.

Bile acid metabolism is an active research area in metabolic disease, and emerging work has begun to explore its relationship with muscle. The evidence here is earlier-stage than for short-chain fatty acids, but it illustrates an important principle: the microbiome extends the body's own chemistry, generating molecules the human genome cannot produce alone.

Bekijk voorbeeldaanbevelingen van het InnerBuddies-platform

Bekijk alvast de aanbevelingen voor voeding, supplementen, het voedingsdagboek en recepten die InnerBuddies kan genereren op basis van je darmmicrobioomtest

Bekijk voorbeeld aanbevelingen

Amino acid availability and protein turnover

Muscle is built from amino acids, and the balance between muscle protein synthesis and muscle protein breakdown determines net muscle mass. The microbiome influences this balance indirectly in several ways.

Some gut bacteria can synthesise certain amino acids, including branched-chain amino acids, and others influence how amino acids from food are absorbed and metabolised. Gut bacteria also compete for some nutrients and can metabolise amino acids that reach the colon, altering what is available systemically.

Additionally, poor gut health with chronic inflammation or diarrhoea can reduce nutrient absorption, which is relevant for older adults already at higher risk of inadequate protein intake. This pathway is less glamorous than microbial metabolites but often more practically important.

Hormonal and energy-sensing pathways: IGF-1 and AMPK

Two signalling systems appear repeatedly in the literature. IGF-1 is a growth factor that supports muscle protein synthesis and is influenced by nutrition, exercise and hormonal status. AMPK is an energy sensor that responds to cellular energy levels and helps regulate metabolism and mitochondrial function.

Animal studies suggest that microbiome status can influence both. Mice raised without a normal gut microbiome, known as germ-free mice, show differences in muscle mass and metabolic markers compared with conventionally raised animals. Transferring gut microbiota from certain mouse models has been shown to reproduce changes in muscle phenotype.

What remains uncertain: translating these findings to humans is difficult. Human IGF-1 levels are influenced by age, liver health, nutrition and exercise, and the microbiome is only one of many inputs. It would be inaccurate to claim that you can meaningfully raise IGF-1 by changing gut bacteria.

Gut barrier integrity

The intestinal lining is a selective barrier. When tight junctions weaken, more bacterial components such as lipopolysaccharide can pass into circulation, prompting immune activation. This low-grade endotoxaemia has been associated with inflammation and insulin resistance, both of which are relevant to muscle.

Terms like "leaky gut" are often used loosely in consumer media, and not every increased intestinal permeability constitutes a disease. However, the underlying concept of barrier function as an inflammatory modulator is scientifically legitimate and continues to be investigated.

A quick summary of mechanisms

The most well-supported pathway is inflammation: the microbiome influences immune tone, and inflammatory cytokines affect muscle protein turnover. Short-chain fatty acid production and gut barrier integrity support this pathway. Bile acid signalling, amino acid metabolism and hormonal effects are plausible contributors with varying levels of evidence. No single mechanism explains everything, which is why thinking in terms of a system is more accurate than looking for a single culprit bacterium.

The Scientific Evidence: Microbiome Signatures and Muscle Health

Research on the gut-muscle axis includes observational human studies, animal experiments and randomised controlled trials, mostly of probiotics. The evidence quality varies considerably, and distinguishing between these categories is essential for interpreting claims responsibly.

What human observational studies suggest

Studies comparing older adults with sarcopenia to those with preserved muscle mass have reported differences in gut microbiota composition. Some findings point toward reduced microbial diversity and shifts in the abundance of specific groups in people with low muscle mass or impaired physical performance.

These results are interesting but limited. Observational studies show associations, not causation. People with sarcopenia may eat differently, take more medications, have different activity levels and experience different inflammatory burdens, all of which independently shape both the microbiome and muscle. Reverse causation is also plausible: lower physical activity could alter the microbiome rather than the other way around.

Specific bacteria that have been studied

Certain strains appear repeatedly in the research literature and in commercial product marketing. It is worth understanding what has actually been shown.

• Lactobacillus reuteri: animal studies have linked certain strains to changes in muscle mass and function, with proposed mechanisms involving immune modulation and gut hormone signalling. Human trials have been small, and results on muscle outcomes have been inconsistent.
• Lactobacillus johnsonii: early work in mouse models has explored effects on muscle metabolism and insulin sensitivity. Human data on muscle endpoints remain limited.
• Bifidobacterium animalis: used in some trials involving older adults, with outcomes sometimes reported for physical performance measures. Effects have been modest and not always reproducible.
• Faecalibacterium prausnitzii and butyrate producers: generally associated with anti-inflammatory profiles and gut barrier health, making them mechanistically relevant to muscle indirectly.

The critical caveat is strain specificity. Effects found with one strain of a species do not automatically apply to another strain, and commercial products vary in strain identity, dose and viability. A 2020s-era review article on the topic cannot be read as evidence for all Lactobacillus products on the market.

Sarcopenia, frailty and age-related muscle loss

Microbiome sarcopenia is an emerging research term describing the potential contribution of age-related microbiome changes to loss of muscle mass and strength. Ageing is associated with shifts in gut microbiota composition, reduced microbiome diversity and increased inflammatory tone, sometimes called inflammageing.

Frailty in older adults has also been associated with differences in microbiota composition in observational studies. These findings provide a biologically plausible rationale for investigating microbiome-targeted interventions in older populations, which is where most clinical interest currently sits.

Animal studies versus human evidence

The table below summarises how the evidence base differs by study type.

Evidence type	What it can show	Key limitation
Animal models (including germ-free mice)	Biological plausibility; mechanistic pathways; cause-and-effect in controlled conditions	Mouse physiology, lifespan, diet and microbiome differ substantially from humans
Human observational studies	Associations between microbial composition and muscle mass, strength or frailty	Cannot establish direction or causation; confounding is likely
Human randomised trials	Effects of specific interventions such as probiotics or fibre on measured outcomes	Often small, short, heterogeneous; outcomes vary; strain specificity limits generalisation
Fecal microbiota transplantation studies	Whether transferring microbiota can transmit a phenotype	Mostly preclinical; limited human data on muscle endpoints

This distinction is where many consumer articles fall short. Headlines often report mouse findings as though they apply directly to people. Responsible interpretation requires holding two ideas at once: the mechanisms are plausible and worth studying, and the human evidence is not yet strong enough to make confident claims.

2-minuten zelfcheck Is een darmmicrobioomtest nuttig voor jou? Beantwoord een paar korte vragen en ontdek of een microbioomtest echt nuttig is voor jou. ✔ Duurt slechts 2 minuten ✔ Gebaseerd op je klachten & leefstijl ✔ Duidelijke ja/nee aanbeveling Check of een test bij mij past →

Probiotics, Prebiotics, and Muscle: What the Research Says

Given the plausible mechanisms, it is unsurprising that probiotics and prebiotics have been studied as potential interventions. The question is not whether the idea is reasonable, but whether the trials support meaningful benefits for muscle outcomes.

Probiotics and muscle strength

Several systematic reviews and meta-analyses have examined whether probiotic supplementation affects muscle strength, muscle mass or physical performance, particularly in older adults. The overall picture is mixed.

Some trials report modest improvements in measures such as handgrip strength or gait speed. Others find no significant difference from placebo. Effects, where present, tend to be small, and the trials vary widely in strain used, dose, duration and population. Many are short-term, with limited follow-up and small sample sizes.

This does not mean probiotics are useless for muscle. It means the evidence is not yet at the stage where a specific product can be recommended for muscle outcomes on the basis of robust clinical data. When a placebo-controlled trial shows a benefit, the question of whether that benefit would occur with a different strain or in a different population remains open.

Prebiotics and dietary fibre

Prebiotics are non-digestible food components, often types of fibre, that selectively feed beneficial gut bacteria. Inulin, oligofructose and resistant starch have been studied in the context of metabolic health, and some research has explored their effects on muscle through pathways involving short-chain fatty acid production and inflammation.

Direct trials of prebiotics on muscle mass are relatively scarce. However, the broader case for adequate fibre intake is strong, and fibre intake is consistently associated with better metabolic health. From a practical standpoint, fibre supports the bacteria that produce the metabolites most plausibly linked to muscle biology.

Which strains show promise

Strains most frequently discussed in the context of muscle and physical function include certain Lactobacillus and Bifidobacterium strains, along with combinations marketed for older adults. Some studies of specific combinations in ageing populations have reported improvements in physical performance measures.

The honest summary: promising signals exist, particularly in older adults, but the evidence is not yet sufficient to identify an optimal strain, dose or duration. Anyone considering probiotics for muscle health should recognise that the marketing language around "probiotics for muscle growth" currently runs ahead of the clinical evidence.

Practical considerations if you are curious

If you decide to try a probiotic, choose products that list specific strains, state viable counts at the end of shelf life and come from manufacturers with quality controls. Introduce changes gradually, note what you are changing, and give it several weeks before judging effects. People with compromised immune systems or serious illness should consult a healthcare professional before starting supplements.

Personalised microbiome analysis can provide context about your starting point, though it will not tell you which probiotic will work for you. Understanding your gut microbiome may, however, help you have a more informed conversation with a clinician or dietitian about your overall gut health.

Dietary Patterns: Fueling the Gut-Microbiome-Muscle Loop

Diet is the most powerful lever most people have over both their microbiome and their muscle. Unlike supplements, dietary patterns have been studied extensively, and several principles are well supported even outside the specific context of the gut-muscle axis.

Protein: the established foundation

Adequate dietary protein is essential for muscle protein synthesis. This is among the best-established findings in nutrition science, and nothing about the microbiome research changes it. Distribution across meals, total daily intake and protein quality all matter, and requirements are generally higher for older adults and physically active people than for sedentary younger adults.

Protein also influences the gut microbiome. Undigested protein reaching the colon can be fermented by bacteria, producing a range of metabolites, some of which are beneficial and some potentially harmful depending on the amount and the bacterial population. Very high protein intakes with low fibre intake may not be optimal for gut health, which is a reminder that muscle-focused and gut-focused nutrition should not be planned in isolation.

Fibre: feeding the bacteria that matter

Dietary fibre is the primary fuel for short-chain fatty acid production. Most people in Western countries consume well below recommended intakes. Increasing fibre gradually from varied plant sources supports microbial diversity and, indirectly, the metabolic and anti-inflammatory pathways discussed earlier.

Variety matters more than any single fibre type. Legumes, whole grains, vegetables, fruit, nuts and seeds each contribute different fermentable substrates and support different bacterial groups.

Fermented foods

Fermented foods such as yoghurt, kefir, sauerkraut, kimchi and some cheeses contain live microorganisms and have been associated with changes in gut microbiota composition in human studies. A notable trial found that a diet high in fermented foods increased microbiota diversity and decreased inflammatory markers over ten weeks.

Fermented foods are not a treatment for muscle loss, but they can be part of a diet that supports both gut and metabolic health. Practical inclusion is usually more sustainable than large-scale supplementation.

Mediterranean-style patterns

The Mediterranean dietary pattern, rich in vegetables, legumes, whole grains, olive oil, fish and nuts, has been associated with both favourable microbiome profiles and better physical function in older adults. It combines high fibre intake, moderate protein and anti-inflammatory food components, making it a reasonable template for supporting both gut and muscle health.

Word lid van de InnerBuddies-community

Voer elke paar maanden een darmmicrobioomtest uit en volg je vooruitgang terwijl je onze aanbevelingen opvolgt

Neem een ​​InnerBuddies-lidmaatschap

Ultra-processed foods and low plant diversity

Diets high in ultra-processed foods and low in plant diversity are consistently associated with less favourable microbiome profiles. The mechanistic explanations involve low fibre intake, additives, emulsifiers and reduced substrate for beneficial bacteria. While research on specific additives is ongoing, the pattern-level association is reasonably consistent.

This is also where measurement can be more informative than guesswork. Rather than assuming your diet is producing a healthy microbiome, a personalised microbiome analysis can offer a snapshot of your composition as a starting point for discussion and monitoring.

The Role of Exercise: A Two-Way Street

Exercise is the other major lever, and its relationship with the gut microbiome runs in both directions.

How exercise changes the microbiome

Regular physical activity, particularly aerobic exercise, has been associated with increased microbial diversity and greater abundance of bacteria that produce short-chain fatty acids. Athletes often show different microbiome profiles from sedentary individuals, although diet and other lifestyle factors confound these comparisons.

Exercise also influences gut transit time, bile acid metabolism and the immune system, all of which can shape the microbial environment. Some research suggests that exercise-induced changes are more pronounced when combined with adequate fibre intake.

How the microbiome may affect exercise and muscle

The reverse direction is less established but actively investigated. Microbiome composition has been associated with differences in muscle function, recovery and even motivation to exercise in animal models. Proposed mechanisms include inflammatory tone, metabolic efficiency and gut-derived signalling to the nervous system.

Resistance training remains the most effective known stimulus for building and preserving muscle mass. Nothing in the microbiome literature changes that. The realistic framing is that gut health may modulate how well your body responds to training and nutrition, not that it replaces them.

A practical combined approach

The most defensible approach to muscle health combines adequate protein, sufficient energy intake, progressive resistance training, adequate fibre and a diverse plant-rich diet. Sleep, stress management and avoiding unnecessary medications also matter. Microbiome-focused strategies sit within this framework as potential contributors, not as substitutes for fundamentals.

From Lab to Life: Current Limitations and Future Directions

Transparency about limitations is essential when discussing an emerging area of science. The research summarised in this article reflects evidence published through the mid-2020s, and it continues to evolve.

The gap between animal and human evidence

Many of the most striking findings on the gut-muscle axis come from rodent models, particularly germ-free mice and faecal microbiota transplantation experiments. These models are valuable for identifying mechanisms, but they cannot be assumed to translate directly. Mice have different gastrointestinal anatomy, different baseline microbiota, different lifespans and different metabolic priorities.

Strain and dose specificity

Probiotic effects are strain-specific and dose-dependent. A meta-analysis pooling different strains can produce an average effect that applies to none of the individual products studied. Consumers reading that "probiotics improve muscle strength" should understand the underlying trials may have used different organisms entirely.

Measurement challenges

Microbiome measurement itself is technically complex. Many studies use 16S rRNA sequencing, which identifies bacteria at the genus level with variable accuracy and cannot reliably assess function. Metagenomic sequencing offers more detail but is less widely used in older trials. Results depend on sample collection, storage and bioinformatics pipelines, making cross-study comparison difficult.

Individual variability

Baseline microbiome composition varies enormously between people, and responses to diet and supplements differ accordingly. A person with high baseline diversity may respond differently from someone with low diversity. This is a key argument against one-size-fits-all recommendations and in favour of personalised approaches.

Theoretical nutrition versus clinical certainty

Much of the mechanistic reasoning in this field is theoretically coherent but not yet clinically confirmed at the level required for specific recommendations. Distinguishing between "biologically plausible" and "proven to benefit human muscle mass" is an essential skill for interpreting this topic accurately.

Where the field is heading

Future directions include larger and longer human trials with muscle-specific endpoints, strain-level characterisation, personalised microbiome-based interventions, investigation of postbiotics and microbial metabolites as therapeutics, and exploration of faecal microbiota transplantation in select clinical contexts. Researchers are also increasingly interested in whether baseline microbiome profiles can predict who responds to protein supplementation or resistance training.

What Microbiome Testing Can and Cannot Tell You

Because the gut-muscle axis is complex and individual, testing has understandable appeal. It is also widely misunderstood, so clarity about its scope is important.

What testing may reveal

• The overall composition and diversity of your gut bacterial community
• The relative abundance of bacterial groups associated with fibre fermentation, inflammation or gut barrier function
• Whether your profile looks broadly typical or shows patterns worth discussing with a professional
• Changes over time in response to diet, exercise or other lifestyle adjustments

What testing cannot establish

• Whether you have sarcopenia or any other muscle condition
• Whether a specific probiotic will improve your muscle strength
• A diagnosis of dysbiosis in a clinically meaningful sense, since no universal definition exists
• How your microbiome is functioning at a metabolic level, since composition does not directly indicate activity
• A replacement for medical assessment of muscle mass, strength or frailty

Testing is best understood as an educational and insight-generating tool. It provides context, not conclusions. Where results suggest something worth investigating, the appropriate next step is a conversation with a qualified healthcare professional who can integrate that information with clinical assessment.

Who May Benefit from Understanding Their Microbiome

Microbiome curiosity is most useful in specific situations. These include people with persistent digestive symptoms who want more structured information before consulting a clinician, older adults thinking about healthy ageing and muscle preservation, people making substantial dietary changes who want an objective baseline, and anyone interested in tracking how lifestyle shifts affect their gut community over time.

2-minuten zelfcheck Is een darmmicrobioomtest nuttig voor jou? Beantwoord een paar korte vragen en ontdek of een microbioomtest echt nuttig is voor jou. ✔ Duurt slechts 2 minuten ✔ Gebaseerd op je klachten & leefstijl ✔ Duidelijke ja/nee aanbeveling Check of een test bij mij past →

It is less useful as a substitute for clinical evaluation of muscle weakness, unexplained weight loss, fatigue or other symptoms that warrant medical assessment. Muscle loss can have many causes, including neurological, endocrine and nutritional conditions, and these require proper investigation.

For those who are simply curious about their gut health as part of a broader wellness picture, a gut microbiome test can serve as a useful reference point. The value lies in what you do with the information, which usually involves dietary adjustments, professional guidance and reasonable patience rather than dramatic interventions.

Key Takeaways

• The gut-muscle axis is a bidirectional communication system linking gut bacteria with skeletal muscle through immune, metabolic and endocrine pathways.
• Chronic low-grade inflammation is the most well-supported mechanism by which the microbiome may influence muscle protein turnover.
• Short-chain fatty acids, gut barrier integrity, bile acid signalling and amino acid metabolism are plausible contributors with varying levels of human evidence.
• Observational studies link microbiome composition to muscle mass and frailty, but associations cannot establish causation.
• Many striking findings come from animal models and should not be assumed to apply directly to humans.
• Probiotic trials show some promising but small and inconsistent effects on muscle strength and physical performance, mainly in older adults.
• Diet remains the most powerful and best-evidenced lever, with protein, fibre and plant diversity supporting both muscle and gut health.
• Resistance training is the most effective stimulus for muscle growth, and exercise also favourably influences the gut microbiome.
• Response to diet and supplements varies substantially between individuals because baseline microbiome composition and function differ.
• Microbiome testing can provide useful context and trends, but it cannot diagnose muscle conditions or predict individual supplement responses.

Frequently Asked Questions

How does the gut microbiota contribute to obesity and muscle loss?

The gut microbiota can influence energy extraction from food, systemic inflammation and insulin sensitivity, all of which interact with body composition. Chronic low-grade inflammation driven partly by microbial signals may promote muscle protein breakdown while impairing synthesis. However, obesity and muscle loss are multifactorial, and the microbiome is one contributor among many rather than a primary cause.

Are there probiotics that can help build muscle?

Some trials in older adults have reported modest improvements in muscle strength or physical performance with certain strains, but results are inconsistent and the evidence is not yet strong enough to recommend a specific product for muscle building. Resistance training, adequate protein and sufficient energy remain the foundation. Anyone considering probiotics should treat them as a possible supportive measure rather than a muscle-building strategy.

What are the signs of a poor gut microbiome?

There is no reliable symptom checklist that identifies an unhealthy microbiome. Persistent bloating, gas, altered bowel habits, unexplained fatigue and frequent digestive discomfort may warrant investigation, but these symptoms have many possible causes. Composition varies widely among healthy people, so symptoms alone are an unreliable guide to microbiome status.

Can changing my diet improve both my gut health and muscle mass?

Yes, diet is the most practical way to influence both. Adequate protein supports muscle protein synthesis, while fibre from varied plant foods feeds bacteria that produce short-chain fatty acids. Fermented foods can support microbial diversity. Improvements tend to be gradual, and consistency over weeks and months matters more than short bursts of change.

What exactly is the gut-muscle axis?

The gut-muscle axis refers to the communication network connecting the gut microbiome with skeletal muscle. It involves immune signalling, microbial metabolites, hormonal pathways and gut barrier function. The term emphasises that this is a system-level relationship rather than a direct anatomical connection.

Does the microbiome affect muscle protein synthesis?

The evidence suggests the microbiome may influence muscle protein synthesis indirectly through inflammation, insulin sensitivity, amino acid availability and energy metabolism. Direct effects on synthesis in humans are not well established. Protein intake and resistance exercise remain the dominant influences on muscle protein synthesis.

Is the gut-muscle axis different in older adults?

Ageing brings changes in microbiome composition, increased inflammatory tone and reduced responsiveness of muscle to protein intake, sometimes called anabolic resistance. Together these may make the gut-muscle axis more relevant in older adults, which is why much research on microbiome sarcopenia and frailty focuses on this population.

Can exercise change my gut bacteria?

Regular physical activity has been associated with increased microbial diversity and greater abundance of short-chain fatty acid producers. Exercise also affects gut transit time and immune function. Effects appear to be more consistent when exercise is combined with a fibre-rich diet.

Are prebiotics useful for muscle health?

Prebiotics support the bacteria that produce short-chain fatty acids, which are mechanistically linked to reduced inflammation and better metabolic health. Direct trials on muscle outcomes are limited, so prebiotics are best viewed as part of an overall fibre-rich dietary pattern rather than a targeted muscle intervention.

How long does it take for diet changes to affect the microbiome?

Some shifts can be detected within days to a few weeks, particularly with large changes in fibre or fermented food intake. More stable, lasting changes typically require consistent dietary habits over months. Microbial composition tends to be resilient and tends to revert if changes are not maintained.

Can microbiome testing tell me whether I am losing muscle?

No. Microbiome testing cannot assess muscle mass, muscle strength or diagnose sarcopenia. Those require clinical measurements such as body composition analysis and functional testing. Microbiome results may provide context about gut health but should never be interpreted as evidence of muscle status.

Do antibiotics affect muscle health through the gut?

Antibiotics can substantially alter gut microbiota composition, and repeated or prolonged use has been associated with reduced diversity. Whether this translates into measurable effects on muscle in humans is not established. Antibiotics should be used when medically indicated, and concerns about microbiome effects should not delay necessary treatment.

Conclusion

The relationship between the gut microbiome and muscle mass is real, biologically plausible and still evolving. The most credible interpretation of the current evidence is that gut bacteria influence the environment in which muscle is built and maintained, primarily through inflammation, metabolic signalling and nutrient handling, rather than acting as a direct controller of muscle growth.

What we know with reasonable confidence is that protein intake, resistance training, dietary fibre and an overall healthy dietary pattern are the foundation of muscle health. What we are still learning is how much the microbiome adds on top of these fundamentals, which strains or strategies might help specific populations, and why responses differ so much between individuals.

That variability is precisely why symptoms and general assumptions are incomplete guides. Two people with similar diets and habits can have different microbiome profiles and different responses to the same intervention. For anyone who wants to move beyond guessing, personalised microbiome insight can add useful context to inform conversations with healthcare professionals, while remaining clear about its limits as an educational tool rather than a diagnosis.

Keywords

gut microbiome and muscle mass, gut-muscle axis, gut bacteria and muscle health, microbiome sarcopenia, probiotics for muscle growth, skeletal muscle, microbiota composition, Lactobacillus reuteri, Lactobacillus johnsonii, Bifidobacterium animalis, muscle strength, muscle atrophy, protein synthesis, short-chain fatty acids, metabolites, inflammation, bile acids, leaky gut, prebiotics, dietary fiber, physical performance, age-related muscle loss, frailty, AMPK, IGF-1, exercise, nutrition, fecal microbiota transplantation, 16S rRNA sequencing, placebo-controlled trial, dysbiosis, microbial diversity, fermented foods, Mediterranean diet, protein turnover, anabolic resistance